Mind-altering substances are (still) falling short in clinical trials

📰 MIT Technology Review

Psychedelics like psilocybin are being researched for various health applications but are falling short in clinical trials

intermediate Published 20 Mar 2026

Action Steps

Research the current clinical trials on psychedelics
Analyze the results and challenges faced by these trials
Explore the potential health applications of psychedelics
Evaluate the market potential and investment opportunities

Who Needs to Know This

Researchers and clinicians on a team benefit from understanding the current state of psychedelics research, and entrepreneurs and investors can gauge the potential market and challenges

Key Insight

💡 Despite promising early results, psychedelics are facing challenges in clinical trials, highlighting the need for further research and development